| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c67387c8f768bb940541c5c45dcf6bf2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 |
| filingDate |
2019-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cee3715697db15496b92ba714d22d7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae385eb56ccfbd94f089684a359c69bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bce0a00474fb38d4df7c53fe0976094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce3da7d4e06c3c23df2fcc58a7bef610
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b125d5678ae0f239df3926b73ecea8b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9686e2cfad1efc6526b690dfb0fae718 |
| publicationDate |
2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2019222052-A1 |
| titleOfInvention |
Benzodiazepine derivative hydrochloride and crystal form, preparation method, and application thereof |
| abstract |
The present invention provides a benzodiazepine derivative hydrochloride represented by formula I or a crystal structure of an ethanolate thereof, wherein R is methyl or ethyl. The present invention further provides a method for preparing a crystal form of the compound represented by formula I, and a pharmaceutical composition comprising the crystal form. |
| priorityDate |
2018-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |